Repurposing drug shows promise in fighting aggressive brain tumors
Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care for these lethal grade 4 brain tumours.
